Drawing for ACCUTIP

USPTO serial 99313787

ACCUTIP

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
SCHRADER, BRITTANY A
Law office
TMO LAW OFFICE 127

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with ACCUTIP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kirk M. Miles

Kirk M. Miles The Webb Law FirmOne Gateway Center420 Fort Duquesne Boulevard, Suite 1200Pittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the transdermal delivery of pharmaceuticals, namely vaccines, anti-viral therapies, immunotherapies, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases and veterinary products for the transdermal delivery of pharmaceuticals, namely vaccines, anti-viral therapies, immunotherapies, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases; medical preparations for the treatment of obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases; medical preparations for immunotherapies; veterinary preparations for the treatment of obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, fertility diseases; veterinary preparations for immunotherapies; medical plasters; all of the above goods not for treating skin diseases; medical dressingsACTIVE—
010Apparatus and instruments for administering medicines being especially those including microneedles and/or microneedle arrangements or structures for use in the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; apparatus and instruments for administering medicines being especially those including microneedles and/or microneedle arrangements for use in the dermal, transdermal, mucosal and transmucosal sampling of body fluids; medical apparatus and instruments for administration of pharmaceuticals and biotechnological molecules using needle-shaped microstructures in the nature of medical , including in the form of plasters to be used on the skin; injection instruments with microneedles for pharmaceuticals; parts of the above goods being especially microneedles and/or microneedle arrangements, for use in the administration of pharmaceuticals and biotechnological moleculesACTIVE—
042Pharmaceutical research and development services, namely, formulation of medicines being medical plasters with microneedles for use on the skinACTIVE—
044Medical consulting of patients and specialist staff, especially physicians, with respect to systems and instruments for administering medicines, especially those including microneedles and/or microneedle arrangements or structures for use in the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; medical services in the nature of formulation and administration of medicines being medical , including through plasters with microneedles for use on the skinACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 11, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 11, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 12, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 12, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 12, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 12, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Feb 12, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2025DOCKASSIGNED TO EXAMINER—
Dec 9, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 31, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 31, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance